Skip to main content

Interpace Biosciences, Inc.

IDXG
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001054102

No open-market purchases or sales by Interpace Biosciences, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesIDXGD

Holders of 5% or more of IDXG

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Interpace Biosciences, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Interpace Biosciences, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

2 Schedule 13D and 13G filings on Interpace Biosciences, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on IDXG
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 14, 202510:49 AM ETSinger Douglas Mark13G/A4.44%195.7K shares−0.71 ppfrom 5.15%Below 5%Jan 10, 2025SEC
Feb 14, 202510:46 AM ETSinger Douglas Mark13G/A5.15%227.0K shares–Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Interpace Biosciences, Inc. shares.

No Form 144 notices for Interpace Biosciences, Inc. are on file.